NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed)

NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access

The National Institute on Drug Abuse seeks to advance its mission by providing the scientific community with the opportunity to request access to biospecimens from the Adolescent Brain Cognitive Development (ABCD) Study, the HEALthy Brain and Child Development (HBCD) Study, and the Population Assessment of Tobacco and Health (PATH) Study to conduct research consistent with study objectives that will maximize the scientific utility of these limited samples. Research proposals should expand the knowledge gained from these studies and advance our understanding the multiple genetic and environmental factors, including exposure to substances, that affect health and disease over the course of a lifetime. Grant authorities that allow NIH to forecast this opportunity are as follows Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 45 CFR Part 75 and 2 CFR Part 200].

Details

• Agency: National Institutes of Health
• Department: Department of Health and Human Services
• Opportunity #: PAR-26-051
• Instrument: grant

Eligibility

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).